Strategic Synergy: Lonza and InduPro Forge Partnership to Redefine the ADC Landscape
In a move that signals a significant shift in the oncology therapeutic pipeline, global manufacturing powerhouse Lonza has entered into...
science
Unlocking the "Cholesterol Trap": New Biological Pathway Offers Hope for Treatment-Resistant Heart Disease
Despite decades of medical advancement and the widespread use of statins and PCSK9 inhibitors, cardiovascular disease (CVD) remains the leading...
California’s Life Sciences Sector: Resilience Amidst a Protracted "Biotech Winter"
Executive Summary: A Powerhouse at a Crossroads California remains the undisputed global epicenter for biotechnology and life sciences innovation, yet...
The Twilight of a Pioneer: Sangamo Therapeutics Files for Chapter 11 Bankruptcy
In a somber turn of events for the biotechnology sector, Sangamo Therapeutics—a Bay Area-based company that effectively birthed the field...
The Dawn of Agentic Science: Nvidia Unveils BioNeMo Toolkit to Revolutionize Biological Discovery
In a move that promises to redefine the landscape of life sciences, Nvidia has officially launched the Nvidia BioNeMo Agent...
Beyond the Surface: Breakthrough Cambridge Study Unveils Hidden Complexity in Severe Pneumonia
Pneumonia remains one of the most formidable challenges in modern medicine. As the world’s leading infectious cause of mortality, it...
Redefining Bioprocessing: Cytomos Unveils the Future of Predictive Cell Analytics with AuraCyt® and Celledonia®
In an era where biopharmaceutical manufacturing is racing to meet the demands of personalized medicine and complex cell therapies, the...
Beyond the Local: How New Genetic Modeling is Rewriting the Map of Schizophrenia
For decades, the search for the genetic underpinnings of schizophrenia has been akin to looking for a lost set of...
The Dark Proteins: How AI is Unlocking Antibiotics from the World of Prions
For decades, the word "prion" has been synonymous with dread in the medical community. Known primarily for their role in...
AbbVie’s $10.9 Billion Acquisition of Apogee Therapeutics: A Strategic Pivot in the Immunology Arms Race
SAN DIEGO — In a move that signals a significant intensification of the global battle for dominance in the immunology...
Intellia Therapeutics: A New Paradigm for Hereditary Angioedema as Gene Editing Nears Commercial Reality
In the rapidly evolving landscape of genetic medicine, few companies have captured the attention of Wall Street and the clinical...
The Microbial Renaissance: NorthX Biologics and enGenes Biotech Forge New Path for E. coli-Based Protein Production
In a move set to redefine the economics and efficiency of biopharmaceutical manufacturing, Swedish contract development and manufacturing organization (CDMO)...
